 |
 |

TAU as a Susceptibility Gene for Amyotropic Lateral SclerosisParkinsonism Dementia Complex of Guam
Parvoneh Poorkaj, PhD;
Debby Tsuang, MD;
Ellen Wijsman, PhD;
Ellen Steinbart, MA;
Ralph M. Garruto, PhD;
Ulla-Katrina Craig, PhD;
Nicola H. Chapman, PhD;
Leojean Anderson, BS;
Thomas D. Bird, MD;
Chris C. Plato, PhD;
Daniel P. Perl, MD;
Wigbert Weiderholt, MD;
Douglas Galasko, MD;
Gerard D. Schellenberg, PhD
Arch Neurol. 2001;58:1871-1878.
Background A Guam variant of amyotrophic
lateral sclerosis (ALS-G) and parkinsonism dementia complex (PDC-G) are
found in the Chamorro people of Guam. Both disorders have overlapping
neuropathologic findings, with neurofibrillary tangles in spinal cord
and brain. The cause of ALS-GPDC-G is unknown, although inheritance
and environment appear important. Because neurofibrillary tangles
containing tau protein are present in ALS-GPDC-G, and
because mutations in the tau gene (TAU) cause autosomal
dominant frontotemporal dementia, TAU was examined as a
candidate gene for ALS-GPDC-G.
Methods TAU was evaluated by DNA sequence
analysis in subjects with ALS-GPDC-G, by linkage analysis of
TAU polymorphisms in an extended pedigree from the village of
Umatac, and by evaluation of linkage disequilibrium with polymorphic
markers flanking and within TAU.
Results Linkage disequilibrium between
ALS-GPDC-G and the TAU polymorphism CA3662 was observed. For
this 2-allele system, PDC and ALS cases were significantly less likely
than Guamanian controls to have the 1 allele (4.9% and 2% vs 11.5%,
respectively; Fisher exact P = .007).
DNA sequence analysis of TAU coding regions did not
demonstrate a mutation responsible for ALS-GPDC-G. Analysis of
TAU genotypes in an extended pedigree of subjects from Umatac
showed obligate recombinants between TAU and ALS-GPDC-G.
Linkage analysis of the Umatac pedigree indicates that TAU is
not the major gene for ALS-GPDC-G.
Conclusions The genetic association between ALS-GPDC-G
implicates TAU in the genetic susceptibility to ALS-GPDC-G.
TAU may be a modifying gene increasing risk for ALS-GPDC-G
in the presence of another, as yet, unidentified gene.
From the Geriatric Research Education Clinical Center (Drs Poorkaj,
Bird, and Schellenberg and Mss Steinbart and Anderson) and Mental
Illness Research Education Clinical Center (Dr Tsuang), Veterans
Affairs Puget Sound Health Care System, Seattle Division, Seattle,
Wash; Division of Gerontology and Geriatric Medicine (Dr Poorkaj) and
Departments of Psychiatry and Behavioral Sciences (Dr Tsuang),
Biostatistics (Drs Wijsman and Chapman), Medicine (Division of Medical
Genetics) (Drs Wijsman and Bird), Neurology (Drs Bird and
Schellenberg), and Pharmacology (Dr Schellenberg), University of
Washington, Seattle; Departments of Anthropology and Biological
Sciences, Binghamton University, State University of New York,
Binghamton, NY (Dr Garruto); National Institute of Neurological
Disorders and Stroke, National Institutes of Health, Bethesda, Md (Dr
Garruto); Department of Public Health, University of Guam, Mangilao (Dr
Craig); Neurosciences Department, University of San Diego, San Diego,
Calif (Drs Plato, Weiderholt, and Galasko); and Departments of
Pathology and Psychology, Mount Sinai School of Medicine, New York, NY
(Dr Perl)
Corresponding author and reprints: Gerard D. Schellenberg, PhD,
GRECC 182-B, Veterans Affairs Puget Sound Health Care System, 1660
S Columbian Way, Seattle, WA 98108 (e-mail: zachdad{at}u.washington.edu).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2001;58(11):1942-1944.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Identification of novel susceptibility loci for Guam neurodegenerative disease: challenges of genome scans in genetic isolates
Sieh et al.
Hum Mol Genet 2009;18:3725-3738.
ABSTRACT
| FULL TEXT
The ALS/PDC syndrome of Guam and the cycad hypothesis
Steele and McGeer
Neurology 2008;70:1984-1990.
ABSTRACT
| FULL TEXT
Quantitative Proteomics Identifies Surfactant-Resistant {alpha}-Synuclein in Cerebral Cortex of Parkinsonism-Dementia Complex of Guam but Not Alzheimer's Disease or Progressive Supranuclear Palsy
Yang et al.
Am. J. Pathol. 2007;171:993-1002.
ABSTRACT
| FULL TEXT
Cycad exposure and risk of dementia, MCI, and PDC in the Chamorro population of Guam
Borenstein et al.
Neurology 2007;68:1764-1771.
ABSTRACT
| FULL TEXT
Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia
Sundar et al.
Hum Mol Genet 2007;16:295-306.
ABSTRACT
| FULL TEXT
Aluminum, Alzheimer's Disease and the Geospatial Occurrence of Similar Disorders
Perl and Moalem
Reviews in Mineralogy and Geochemistry 2006;64:115-134.
FULL TEXT
A TRPM7 variant shows altered sensitivity to magnesium that may contribute to the pathogenesis of two Guamanian neurodegenerative disorders
Hermosura et al.
Proc. Natl. Acad. Sci. USA 2005;102:11510-11515.
ABSTRACT
| FULL TEXT
Genome-Wide Analysis of the Parkinsonism-Dementia Complex of Guam
Morris et al.
Arch Neurol 2004;61:1889-1897.
ABSTRACT
| FULL TEXT
A Clustering of Conjugal Amyotrophic Lateral Sclerosis in Southeastern France
Corcia et al.
Arch Neurol 2003;60:553-557.
ABSTRACT
| FULL TEXT
Genetic Modulation of Tau Phosphorylation in the Mouse
Brich et al.
J. Neurosci. 2003;23:187-192.
ABSTRACT
| FULL TEXT
Tau and {alpha}-Synuclein Pathology in Amygdala of Parkinsonism-Dementia Complex Patients of Guam
Forman et al.
Am. J. Pathol. 2002;160:1725-1731.
ABSTRACT
| FULL TEXT
|